Pancreatic Cancer Research

ResearcherInner Mongolia Medical UniversityActive in the last 2 years

Rui Xiao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8395-1041; OpenAlex author ID A5037071899, A5131226111. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 2 papers

Papers 3

  1. FABP4 interacts with PPARγ to promote malignant progression in pancreatic cancer. Last author DOI 10.1016/j.isci.2026.116547↗
  2. A novel AGTPBP1-ERK/MYLK network mediates pancreatic cancer progression. Co-author DOI 10.1016/j.tice.2026.103512↗
  3. Targeting AGTPBP1 inhibits pancreatic cancer progression via regulating microtubules and ERK signaling pathway. Co-author DOI 10.1186/s10020-024-00892-x↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jian-jun Ren · 3 shared papers, 2024–2026 · strength 0.86
  2. Jingrui Yang · 1 shared paper, 2026 · strength 0.32
  3. Zhe-yu Yang · 1 shared paper, 2026 · strength 0.32
  4. Chenxi Yang · 1 shared paper, 2026 · strength 0.32
  5. Ding-zhong Li · 1 shared paper, 2024 · strength 0.23
  6. Qian Zhang · 1 shared paper, 2024 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.